Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Influence of Darolutamide on Cabazitaxel Systemic Exposure.
Buck SAJ, Guchelaar NAD, de Bruijn P, Ghobadi Moghaddam-Helmantel IM, Oomen-de Hoop E, Westgeest HM, Hamberg P, Mathijssen-van Stein D, Lolkema MP, Koolen SLW, de Wit R, Mathijssen RHJ. Buck SAJ, et al. Among authors: de bruijn p, de wit r. Clin Pharmacokinet. 2022 Oct;61(10):1471-1473. doi: 10.1007/s40262-022-01159-6. Epub 2022 Jul 27. Clin Pharmacokinet. 2022. PMID: 35895277 No abstract available.
Modulation of irinotecan metabolism by ketoconazole.
Kehrer DF, Mathijssen RH, Verweij J, de Bruijn P, Sparreboom A. Kehrer DF, et al. Among authors: de bruijn p. J Clin Oncol. 2002 Jul 15;20(14):3122-9. doi: 10.1200/JCO.2002.08.177. J Clin Oncol. 2002. PMID: 12118026 Clinical Trial.
Effects of St. John's wort on irinotecan metabolism.
Mathijssen RH, Verweij J, de Bruijn P, Loos WJ, Sparreboom A. Mathijssen RH, et al. Among authors: de bruijn p. J Natl Cancer Inst. 2002 Aug 21;94(16):1247-9. doi: 10.1093/jnci/94.16.1247. J Natl Cancer Inst. 2002. PMID: 12189228 Free article. Clinical Trial.
A pharmacokinetic interaction study of docetaxel and cisplatin plus or minus 5-fluorouracil in the treatment of patients with recurrent or metastatic solid tumors.
Felici A, Loos WJ, Verweij J, Cirillo I, de Bruijn P, Nooter K, Mathijssen RH, de Jonge MJ. Felici A, et al. Among authors: de bruijn p, de jonge mj. Cancer Chemother Pharmacol. 2006 Nov;58(5):673-80. doi: 10.1007/s00280-006-0221-x. Epub 2006 Mar 17. Cancer Chemother Pharmacol. 2006. PMID: 16544143 Clinical Trial.
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study.
de Jong FA, Kehrer DF, Mathijssen RH, Creemers GJ, de Bruijn P, van Schaik RH, Planting AS, van der Gaast A, Eskens FA, Janssen JT, Ruit JB, Verweij J, Sparreboom A, de Jonge MJ. de Jong FA, et al. Among authors: de bruijn p, de jonge mj. Oncologist. 2006 Sep;11(8):944-54. doi: 10.1634/theoncologist.11-8-944. Oncologist. 2006. PMID: 16951398 Free article. Clinical Trial.
141 results